Anil Chitkara - 24 Oct 2025 Form 4 Insider Report for Evolv Technologies Holdings, Inc. (EVLV)

Role
Founder & Chief Growth Officer
Signature
/s/ Rachel Roy, Attorney-in-fact for Anil Chitkara
Issuer symbol
EVLV
Transactions as of
24 Oct 2025
Net transactions value
-$2,850,436
Form type
4
Filing time
28 Oct 2025, 16:03:48 UTC
Previous filing
04 Mar 2025
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Chitkara Anil Founder & Chief Growth Officer C/O EVOLV TECHNOLOGIES HOLDINGS, INC., 500 TOTTEN POND ROAD, 4TH FLOOR, WALTHAM /s/ Rachel Roy, Attorney-in-fact for Anil Chitkara 27 Oct 2025 0001870900

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVLV Class A Common Stock Options Exercise $16,939 +70,581 +5.5% $0.2400 1,345,681 24 Oct 2025 Direct
transaction EVLV Class A Common Stock Options Exercise $28,800 +120,000 +8.9% $0.2400 1,465,681 24 Oct 2025 Direct
transaction EVLV Class A Common Stock Options Exercise $20,756 +49,419 +3.4% $0.4200 1,515,100 24 Oct 2025 Direct
transaction EVLV Class A Common Stock Sale $578,764 -70,581 -4.7% $8.20 1,444,519 24 Oct 2025 Direct F1
transaction EVLV Class A Common Stock Sale $984,000 -120,000 -8.3% $8.20 1,324,519 24 Oct 2025 Direct F1
transaction EVLV Class A Common Stock Sale $405,236 -49,419 -3.7% $8.20 1,275,100 24 Oct 2025 Direct F1
transaction EVLV Class A Common Stock Options Exercise $20,442 +85,173 +6.7% $0.2400 1,360,273 27 Oct 2025 Direct
transaction EVLV Class A Common Stock Options Exercise $14,627 +34,827 +2.6% $0.4200 1,395,100 27 Oct 2025 Direct
transaction EVLV Class A Common Stock Sale $984,000 -120,000 -8.6% $8.20 1,275,100 27 Oct 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLV Stock Option (Right to Buy) Options Exercise $0 -70,581 -6.7% $0.000000 988,497 24 Oct 2025 Class A Common Stock 70,581 $0.2400 Direct F3
transaction EVLV Stock Option (Right to Buy) Options Exercise $0 -120,000 -12% $0.000000 868,497 24 Oct 2025 Class A Common Stock 120,000 $0.2400 Direct F3
transaction EVLV Stock Option (Right to Buy) Options Exercise $0 -49,419 -7.5% $0.000000 611,795 24 Oct 2025 Class A Common Stock 49,419 $0.4200 Direct F4
transaction EVLV Stock Option (Right to Buy) Options Exercise $0 -85,173 -9.8% $0.000000 783,324 27 Oct 2025 Class A Common Stock 85,173 $0.2400 Direct F3
transaction EVLV Stock Option (Right to Buy) Options Exercise $0 -34,827 -5.7% $0.000000 576,968 27 Oct 2025 Class A Common Stock 34,827 $0.4200 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.03 to $8.34. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.13 to $8.30. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The stock option vested and became exercisable as to 25% of the underlying shares on January 31, 2018 and in 36 equal monthly installments thereafter.
F4 The stock option vested and became exercisable as to 25% of the underlying shares on January 1, 2022 and in 36 equal monthly installments thereafter.